Cargando…
Pretreatment with Erythropoietin Attenuates Lung Ischemia/Reperfusion Injury via Toll-Like Receptor-4/Nuclear Factor-κB (TLR4/NF-κB) Pathway
BACKGROUND: Lung ischemia/reperfusion injury (LIRI) is a medical problem featuring pulmonary dysfunction and damage. The present study aimed to investigate the protective effects of erythropoietin (EPO), which has been reported to be an anti-inflammatory agent, on LIRI through inhibiting the TLR-4/N...
Autores principales: | He, Qian, Zhao, Xueshan, Bi, Siwei, Cao, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842661/ https://www.ncbi.nlm.nih.gov/pubmed/29493564 http://dx.doi.org/10.12659/MSM.905690 |
Ejemplares similares
-
(−)-Epigallocatechin-3-Gallate Protects Against Lithium-Pilocarpine-Induced Epilepsy by Inhibiting the Toll-Like Receptor 4 (TLR4)/Nuclear Factor-κB (NF-κB) Signaling Pathway
por: Qu, Zhenzhen, et al.
Publicado: (2019) -
Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway
por: Zhai, Yongyi, et al.
Publicado: (2020) -
Vildagliptin Attenuates Hepatic Ischemia/Reperfusion Injury via the TLR4/NF-κB Signaling Pathway
por: Sherif, Iman O., et al.
Publicado: (2018) -
The effect of focal cerebral ischemia-reperfusion injury on TLR4 and NF-κB signaling pathway
por: Chen, Jing, et al.
Publicado: (2018) -
Pretreatment with geniposide mitigates myocardial ischemia/reperfusion injury by modulating inflammatory response through tLr4/NF-κb pathway
por: Yao, Yanmei, et al.
Publicado: (2023)